Last week, the FDA approved the Immucor PreciseType Human Erythrocyte Antigen (HEA) Molecular BeadChip assay. This method determines non-ABO antigens on red blood cells and is the first molecular assay for determining blood compatibility to be approved by the FDA.
What do you think, blood bankers? When it comes to blood compatibility, do you trust molecular diagnostics as much as serological methods?
One thought on “Molecular Testing in Transfusion Medicine”